Status:
COMPLETED
Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects
Lead Sponsor:
Yale University
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the performance of a non-invasive olfactory device as a rapid indicator of COVID-19 in positive subjects.
Detailed Description
The major hypothesis is that a quantitative and unbiased smell test will be a useful tool to identify COVID-19 positive individuals. The study will address what fraction of outpatients truly have a l...
Eligibility Criteria
Inclusion
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Have a corresponding PCR test for SARS-CoV-2 on the same day.
Exclusion
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Individuals with allergic to fragrances
- History of surgery on the nose or paranasal sinuses
- Asthmatics
- Patients with known neurocognitive disorders: dementia, Alzheimer's disease, Parkinson's disease
- Adults with Acute or Chronic rhinosinusitis (They will be asked if they have a 'stuffy or runny nose'; they may be included in some tests, but their analysis would be segregated as they may be false positives due to allergies or a common cold or flu)
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 18 2020
Estimated Enrollment :
1320 Patients enrolled
Trial Details
Trial ID
NCT04431908
Start Date
June 15 2020
End Date
November 18 2020
Last Update
June 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale New Haven Hospital
New Haven, Connecticut, United States, 06519